CIK 0001699382 · Non-accelerated filer<br>Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463218129
- Phone
- (609) 642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-30 | Schroeder Thilo Director | Sale | −13,233 | $30.05 | $398K | 1,242,708 |
| 2021-08-27 | Schroeder Thilo Director | Sale | −23,397 | $30.50 | $714K | 1,256,986 |
| 2021-08-27 | Schroeder Thilo Director | Sale | −1,045 | $31.06 | $32K | 1,255,941 |
| 2021-08-26 | Schroeder Thilo Director | Sale | −15,063 | $30.39 | $458K | 1,286,474 |
| 2021-08-26 | Schroeder Thilo Director | Sale | −6,091 | $31.13 | $190K | 1,280,383 |
| 2021-08-25 | Schroeder Thilo Director | Sale | −13,526 | $31.01 | $419K | 1,585,953 |
| 2021-08-24 | Schroeder Thilo Director | Sale | −14,490 | $31.08 | $450K | 1,599,479 |
| 2021-08-23 | Schroeder Thilo Director | Sale | −23,138 | $30.66 | $709K | 1,614,669 |
| 2021-08-23 | Schroeder Thilo Director | Sale | −700 | $31.06 | $22K | 1,613,969 |
| 2021-08-23 | LEVINE ARNOLD J Director | Sale | −3,500 | $29.50 | $103K | 413,342 |
| 2021-08-19 | Schroeder Thilo Director | Sale | −3,800 | $30.97 | $118K | 1,637,807 |
| 2021-08-19 | Mack David Henry President and CEO | Option exercise | +5,500 | $0.53 | $3K | 17,970 |
| 2021-08-19 | Mack David Henry President and CEO | Option exercise · Stock Option (right to buy) | −5,500 | 441,574 | ||
| 2021-08-19 | Kung Winston COO, CFO | Option exercise | +5,000 | $3.22 | $16K | 6,600 |
| 2021-08-19 | Kung Winston COO, CFO | Option exercise · Stock Option (right to buy) | −5,000 | 214,034 | ||
| 2021-08-18 | Schroeder Thilo Director | Sale | −11,431 | $32.57 | $372K | 1,657,040 |
| 2021-08-18 | Schroeder Thilo Director | Sale | −13,196 | $33.84 | $447K | 1,643,844 |
| 2021-08-18 | Schroeder Thilo Director | Sale | −2,237 | $34.32 | $77K | 1,641,607 |
| 2021-08-17 | Jalota Deepika SVP, Regulatory Affairs and QA | Option exercise | +2,896 | $3.53 | $10K | 2,896 |
| 2021-08-17 | Jalota Deepika SVP, Regulatory Affairs and QA | Sale | −2,896 | $33.78 | $98K | 0 |
Page 8 of 10 · 196 trades